The ACT-NOW programme looks at how systemic therapy (eg chemotherapy) is being delivered across the motu and uses national data to identify ways systemic therapy can be improved. Although affected by COVID-19, ACT-NOW regimen development and publication has continued.
The ACT-NOW data specification, outlining key data items for national collection to support analyses into equity, clinical quality, and resource planning has been finalised and implementation planning for this standard is underway with providers and software vendors.
We have worked closely with Te Whatu Ora Data and Digital to build and test a prototype IT infrastructure to receive, validate, store, link and analyse ACT-NOW data. Current work focuses on the automation of data quality checks to ensure that data fed into the ACT-NOW programme meets minimum accuracy and completeness standards.
In collaboration with our steering group and other sector stakeholders we have developed and continue to refine pieces of analysis that focus on supporting equity and clinical quality. Key questions we are seeking to answer include:
- Who is accessing systemic therapy and where are the key gaps in access?
- How long do people wait to receive systemic therapy once they are diagnosed?
- How far do people need to travel to receive systemic therapy?
- What types of medicines are people receiving and are these in-line with best-practice standards?
- What are the outcomes for people receiving chemotherapy, is there national variation and how does NZ compare with other countries?
If you would like more information on ACT-NOW contact Alexander.Dunn@teaho.govt.nz